Company Filing History:
Years Active: 2025
Title: Darragh Maccann: Innovator in Biopharmaceuticals
Introduction
Darragh Maccann is a notable inventor based in Magherafelt, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic compositions. With a total of 2 patents to his name, Maccann is recognized for his work in targeting specific antigens for treatment purposes.
Latest Patents
Maccann's latest patents include compositions targeting prostate-specific membrane antigen and methods for making and using the same. This patent describes antigen-binding molecules with specificity to the cluster of differentiation T cell receptor (CD) and prostate-specific membrane antigen (PSMA). It also covers cleavable linker sequences and protease-activatable bispecific fusion proteins, including protease-activatable T cell engagers, along with their uses and methods of treatment. Another significant patent is for HER-2 targeted bispecific compositions and methods for making and using the same. This disclosure includes polypeptides and methods for creating bispecific antibody constructs that are covalently linked to extended recombinant polypeptides, which can be cleaved by proteases to release the bispecific antibody construct.
Career Highlights
Darragh Maccann is currently associated with Amunix Pharmaceuticals, Inc., where he continues to innovate in the biopharmaceutical sector. His work focuses on developing advanced therapeutic solutions that can significantly impact patient care.
Collaborations
Maccann has collaborated with notable professionals in his field, including Volker Schellenberger and Eric Johansen. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Darragh Maccann is a prominent figure in the biopharmaceutical industry, known for his innovative patents and contributions to targeted therapies. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.